Back to results
UnknownPhase 4

Efficacy of Acarbose on Intestinal Microbiome and Incretins of Type 2 Diabetes

NCT01758471

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Shanghai Clinic Center for Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Institute for Endocrine and Metabolic Diseases

Shanghai, Shanghai Municipality, China

Contact

Guang Ning, M.D. Ph.D.

86-021-64370045guangning@medmail.com.cn
View on ClinicalTrials.gov
Efficacy of Acarbose on Intestinal Microbiome and Incretins of Type 2 Diabetes — TrialFind